Results 1 to 10 of about 107,169 (228)

Knowledge and risk perceptions of the Ebola virus in the United States [PDF]

Preventive Medicine Reports, 2015
Objectives: The Ebola epidemic has received extensive media coverage since the first diagnosed cases of the virus in the US. We investigated risk perceptions of Ebola among individuals living in the US and measured their knowledge of the virus.
Jonathan J. Rolison, Yaniv Hanoch
doaj   +5 more sources

Prevention of sexual transmission of Ebola in Liberia through a national semen testing and counselling programme for survivors: an analysis of Ebola virus RNA results and behavioural data [PDF]

The Lancet Global Health, 2016
Background: Ebola virus has been detected in semen of Ebola virus disease survivors after recovery. Liberia's Men's Health Screening Program (MHSP) offers Ebola virus disease survivors semen testing for Ebola virus.
Moses J Soka, MD, Dr. Mary J Choi, MD, April Baller, MRCGP, Stephen White, MSc, Emerson Rogers, BSc, Lawrence J Purpura, MD, Nuha Mahmoud, MD, Christine Wasunna, PhD, Moses Massaquoi, MD, Neetu Abad, PhD, Jomah Kollie, RN, Straker Dweh, Philip K Bemah, MD, Athalia Christie, MIA, Victor Ladele, MBBS, Oneychachi C Subah, BSc, Satish Pillai, MD, Margaret Mugisha, MPH, Jonathan Kpaka, BSc, Stephen Kowalewski, BS, Emilio German, MSHSA, Mark Stenger, MA, Stuart Nichol, PhD, Ute Ströher, PhD, Kristin E Vanderende, PhD, Shauna Mettee Zarecki, MSN, Hugh Henry W Green, MPH, Jeffrey A Bailey, MD, Pierre Rollin, MD, Barbara Marston, MD, Tolbert G Nyenswah, MPH, Alex Gasasira, MBChB, Barbara Knust, DVM, Desmond Williams, MD   +33 more
doaj   +2 more sources

Seroprevalence of Ebola virus infection in Bombali District, Sierra Leone [PDF]

Journal of Public Health in Africa, 2017
A serosurvey of anti-Ebola Zaire virus nucleoprotein IgG prevalence was carried out among Ebola virus disease survivors and their Community Contacts in Bombali District, Sierra Leone. Our data suggest that the specie of Ebola virus (Zaire) responsible of
Nadege Goumkwa Mafopa, Gianluca Russo, Raoul Emeric Guetiya Wadoum, Emmanuel Iwerima, Vincent Batwala, Marta Giovanetti, Antonella Minutolo, Patrick Turay, Thomas B. Turay, Brima Kargbo, Massimo Amicosante, Mattei Maurizio, Carla Montesano, Ebola Study Group   +13 more
doaj   +4 more sources

Detection of Antibodies against the Four Subtypes of Ebola Virus in Sera from Any Species Using a Novel Antibody-Phage Indicator Assay [PDF]

, 2002
The natural host for Ebola virus, presumed to be an animal, has not yet been identified despite an extensive search following several major outbreaks in Africa.
Burton, Dennis R., Frentsch, Marco, Geisbert, Tom W., Hessell, Ann J., Jahrling, Peter B., Maruyama, Toshiaki, Meissner, Felix, Parren, Paul W.H.I., Rodriguez, Luis L.   +8 more
core   +2 more sources

Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries

Trials, 2021
Introduction The Ebola virus disease (EVD) outbreak in 2014–2016 in West Africa was the largest on record and provided an opportunity for large clinical trials and accelerated efforts to develop an effective and safe preventative vaccine.
Moses Badio, Edouard Lhomme, Mark Kieh, Abdoul Habib Beavogui, Stephen B. Kennedy, Seydou Doumbia, Bailah Leigh, Samba O. Sow, Alpha Diallo, Daniela Fusco, Matthew Kirchoff, Monique Termote, Renaud Vatrinet, Deborah Wentworth, Helène Esperou, H. Clifford Lane, Jerome Pierson, Deborah Watson-Jones, Céline Roy, Eric D’Ortenzio, Brian Greenwood, Genevieve Chêne, Laura Richert, James D. Neaton, Yazdan Yazdanpanah, the PREVAC study team   +25 more
doaj   +1 more source

What did we learn from preparing for cross-border transmission of Ebola virus disease into a complex humanitarian setting – The Republic of South Sudan?

Infectious Diseases of Poverty, 2020
Background Following the West Africa Ebola virus disease (EVD) outbreak (2013–2016), WHO developed a preparedness checklist for its member states. This checklist is currently being applied for the first time on a large and systematic scale to prepare for
Olushayo Oluseun Olu, Richard Lako, Joseph Francis Wamala, Patrick Otim Ramadan, Caroline Ryan, Ifeanyi Udenweze, Kibebu Berta, Argata Guracha Guyo, Alex Sokemawu, Michael Tukuru, Henry John Gray, Alex Chimbaru   +11 more
doaj   +1 more source

Predicting the extinction of Ebola spreading in Liberia due to mitigation strategies [PDF]

, 2015
The Ebola virus is spreading throughout West Africa and is causing thousands of deaths. In order to quantify the effectiveness of different strategies for controlling the spread, we develop a mathematical model in which the propagation of the Ebola virus
Braunstein, L. A., Rêgo, H. H. A., Stanley, H. E., Valdez, L. D.   +3 more
core   +5 more sources

Adult and paediatric haematology and clinical chemistry laboratory reference limits for Liberia

African Journal of Laboratory Medicine, 2020
Background: As more research is conducted in Liberia, there is a need for laboratory reference limits for common chemistry and haematology values based on a healthy population. Reference limits from the United States may not be applicable.
Mark W. Kieh, Sarah M. Browne, Greg A. Grandits, Julie Blie, Jestina W. Doe-Anderson, Marie L. Hoover, Bionca Davis, Cavan S. Reilly, James D. Neaton, H. Clifford Lane, Stephen B. Kennedy   +10 more
doaj   +1 more source

TIM-1 Augments Cellular Entry of Ebola Virus Species and Mutants, Which Is Blocked by Recombinant TIM-1 Protein

Microbiology Spectrum, 2022
Ebola virus, a member of the Filoviridae family, utilizes the attachment factors on host cells to support its entry and cause severe tissue damage. TIM-1 has been identified as a predominant attachment factor via interaction with phosphatidylserine (PS ...
Min Zhang, Xinwei Wang, Linhan Hu, Yuting Zhang, Hang Zheng, Haiyan Wu, Jing Wang, Longlong Luo, He Xiao, Chunxia Qiao, Xinying Li, Weijin Huang, Youchun Wang, Jiannan Feng, Guojiang Chen   +14 more
doaj   +1 more source

Recombinant Sudan virus and evaluation of humoral cross-reactivity between Ebola and Sudan virus glycoproteins after infection or rVSV-ΔG-ZEBOV-GP vaccination

Emerging Microbes and Infections, 2023
Ebola disease outbreaks are major public health events because of human-to-human transmission and high mortality. These outbreaks are most often caused by Ebola virus, but at least three related viruses can also cause the disease. In 2022, Sudan virus re-
Markus H. Kainulainen, Jessica R. Harmon, Amy N. Whitesell, Éric Bergeron, Elif Karaaslan, Caitlin M. Cossaboom, Jason H. Malenfant, Aaron Kofman, Joel M. Montgomery, Mary J. Choi, César G. Albariño, Christina F. Spiropoulou   +11 more
doaj   +1 more source